Literature DB >> 34195735

Fluorescence imaging of pathophysiological microenvironments.

Shan Wang1, Wen Xiu Ren2, Ji-Ting Hou1, Miae Won3, Jusung An3, Xiaoyuan Chen4, Jian Shu2, Jong Seung Kim3.   

Abstract

Abnormal microenvironments (viscosity, polarity, pH, etc.) have been verified to be closely associated with numerous pathophysiological processes such as inflammation, neurodegenerative diseases, and cancer. As a result, deep insights into these pathophysiological microenvironments are particularly beneficial for clinical diagnosis and treatment. However, the monitoring of pathophysiological microenvironments is unattainable by the traditional clinical diagnostic techniques such as magnetic resonance imaging, computed tomography, and positron emission tomography. Recently, fluorescence imaging has shown tremendous advantages and potential in the tracing of pathophysiological microenvironment variations. In this context, a general discussion is provided on the state-of-the-art progress of fluorescent probes for visualizing pathophysiological microenvironments (viscosity, pH, and polarity), since 2016, as well as the future perspectives in this challenging field.

Entities:  

Year:  2021        PMID: 34195735     DOI: 10.1039/d1cs00083g

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  3 in total

1.  High-fidelity carbon dots polarity probes: revealing the heterogeneity of lipids in oncology.

Authors:  Jingyu Hu; Yuanqiang Sun; Xin Geng; Junli Wang; Yifei Guo; Lingbo Qu; Ke Zhang; Zhaohui Li
Journal:  Light Sci Appl       Date:  2022-06-20       Impact factor: 20.257

2.  Polymeric dual-modal imaging nanoprobe with two-photon aggregation-induced emission for fluorescence imaging and gadolinium-chelation for magnetic resonance imaging.

Authors:  Xueyang Xiao; Hao Cai; Qiaorong Huang; Bing Wang; Xiaoming Wang; Qiang Luo; Yinggang Li; Hu Zhang; Qiyong Gong; Xuelei Ma; Zhongwei Gu; Kui Luo
Journal:  Bioact Mater       Date:  2022-05-07

3.  TME-targeting theranostic agent uses NIR tracking for tumor diagnosis and surgical resection and acts as chemotherapeutic showing enhanced efficiency and minimal toxicity.

Authors:  Zhongyuan Xu; Jianqiang Qian; Chi Meng; Yun Liu; Qian Ding; Hongmei Wu; Peng Li; Fansheng Ran; Gong-Qing Liu; Yunyun Wang; Yong Ling
Journal:  Theranostics       Date:  2022-02-28       Impact factor: 11.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.